Peptide dendrimers as "lead compounds" for the treatment of chronic lung infections by in cystic fibrosis patients: in vitro and in vivo studies
about
Peptide dendrimers as "lead compounds" for the treatment of chronic lung infections by in cystic fibrosis patients: in vitro and in vivo studies
description
im Jahr 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Peptide dendrimers as "lead co ...... : in vitro and in vivo studies
@en
Peptide dendrimers as "lead co ...... : in vitro and in vivo studies
@nl
type
label
Peptide dendrimers as "lead co ...... : in vitro and in vivo studies
@en
Peptide dendrimers as "lead co ...... : in vitro and in vivo studies
@nl
prefLabel
Peptide dendrimers as "lead co ...... : in vitro and in vivo studies
@en
Peptide dendrimers as "lead co ...... : in vitro and in vivo studies
@nl
P2093
P2860
P356
P1476
Peptide dendrimers as "lead co ...... : in vitro and in vivo studies
@en
P2093
Arianna Pompilio
Cristina Geminiani
Ivan Di Bonaventura
Jean Louis Reymond
Thissa N Siriwardena
P2860
P304
P356
10.2147/IDR.S168868
P407
P577
2018-01-01T00:00:00Z